Molecular and Immunological assessment of anticancer activity of 1,2,4-triazolo[4,3-b] [1,2,4] triazole derivative in combination with Artemisia Judaica Extract in Murine Lung cancer model. | ||||
Journal of Medical and Life Science | ||||
Volume 7, Issue 1, March 2025, Page 60-84 PDF (2.96 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jmals.2025.410693 | ||||
![]() | ||||
Authors | ||||
Abdel Aziz Zidane1; Elsayed Abdel Rehem Mahmoud2; Amira Hamisa1; El-Hassan Mokhamer* 1 | ||||
1Zoology Department, Faculty of Science, Damanhour University | ||||
2Chemistry Department, Faculty of Science, Damanhour University | ||||
Abstract | ||||
Lung cancer remains a leading cause of cancer-related mortality worldwide, emphasizing the urgent need for innovative therapeutic strategies. This study evaluates the anti-cancer impact of Artemisia Judaica (AJ) and 1,2,4-triazole derivatives (TRI), both individually and in combination, against lung cancer. Immunohistochemical (IHC) analysis revealed significant modulation in the expression of Caspase-3, Caspase-7, and tumor necrosis factor-alpha (TNF-α), indicating enhanced apoptosis and immune responses. Molecular investigations further demonstrated the compounds’ regulatory effects on key oncogenic pathways, specifically EGFR and BRAF. Notably, the combined therapy displayed a synergistic effect, underscoring its potential as a novel therapeutic approach for lung cancer. These findings highlight AJ and 1,2,4-triazole derivatives as promising candidates for further clinical evaluation and development in lung cancer management. | ||||
Keywords | ||||
lung Cancer; Artemisia Judaica; 1; 2; 4-triazole derivatives; caspase-3; caspase-7; TNF-α | ||||
Statistics Article View: 262 PDF Download: 166 |
||||